FIELD: medicinal molecular biology, peptides, pharmacy. SUBSTANCE: invention relates to novel peptide sequences and their analogues showing properties of agonists of apolipoprotein A-1 (Apo-A-1) by their administration in effective doses to patient. Such analogues are used for treatment of different disorders associated with dyslipidemia. Invention comprises data about corresponding chemical structures, different complexes of such lipids, in part, with lipids as component pharmaceutical compositions and methods for treatment of dyslipidemic disorders. EFFECT: expanded assortment of agents in therapy of different dyslipidemic states. 51 cl, 10 tbl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| GENE-THERAPEUTIC METHODS FOR ADMINISTRATION OF APOLIPOPROTEIN A-1 AGONISTS AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2222545C2 |
| AGONISTS OF APOLIPOPROTEIN A-I AND THEIR USING FOR TREATMENT OF DYSLIPIDEMIA-MEDIATED DISEASES | 1998 |
|
RU2215747C2 |
| AGONISTS OF APOLIPOPROTEIN A-1 AND THEIR APPLICATION FOR TREATMENT OF DYSLIPIDEMIA-ASSOCIATED DISEASES | 1998 |
|
RU2219941C2 |
| A-I APOLIPOPROTEIN MIMETICS | 2010 |
|
RU2532222C2 |
| CYCLIC ANALOGUES OF GALANIN AND METHOD OF THEIR APPLICATION | 2016 |
|
RU2727013C2 |
| JOINT LYOPHILIZATION-MEDIATED FORMATION OF PEPTIDE-LIPID COMPLEX | 1998 |
|
RU2224506C2 |
| THERAPEUTIC USE OF GLUCAGON AND ITS COMBINATION | 2019 |
|
RU2838895C2 |
| DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS | 2013 |
|
RU2652783C2 |
| POLYPEPTIDE DEMONSTRATING ANTIBACTERIAL ACTIVITY AND SUITABLE FOR OBTAINING THERAPEUTIC MEDICATIONS FOR TREATMENT OF HUMAN BACTERIAL INFECTIONS | 2010 |
|
RU2434880C1 |
| HUMAN AMYLIN ANALOG POLYPEPTIDES AND METHODS OF USE THEREOF | 2019 |
|
RU2839688C2 |
